1.
Rhinology
; 60(6): 474-478, 2022 Dec 01.
Article
in English
| MEDLINE
| ID: mdl-36436220
ABSTRACT
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.
Subject(s)
Antibodies, Monoclonal, Humanized , Quality of Life , Humans , Antibodies, Monoclonal, Humanized/therapeutic use
2.
Lung
; 197(1): 105-106, 2019 02.
Article
in English
| MEDLINE
| ID: mdl-30506167